Viewing Study NCT02864758

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 12:00 AM

Ignite Modification Date: 2026-02-25 @ 5:34 PM

Study NCT ID: NCT02864758

Status: COMPLETED

Last Update Posted: 2023-11-07

First Post: 2016-08-09

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France

Sponsor: Bayer

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module